Jay Gunawardana
Jay Gunawardana
Verified email at mater.uq.edu.au
Title
Cited by
Cited by
Year
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
R Kridel, B Meissner, S Rogic, M Boyle, A Telenius, B Woolcock, ...
Blood, The Journal of the American Society of Hematology 119 (9), 1963-1971, 2012
3382012
Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma
DDW Twa, FC Chan, S Ben-Neriah, BW Woolcock, A Mottok, KL Tan, ...
Blood, The Journal of the American Society of Hematology 123 (13), 2062-2065, 2014
2612014
Meningococcal porin PorB binds to TLR2 and requires TLR1 for signaling
P Massari, A Visintin, J Gunawardana, KA Halmen, CA King, ...
The Journal of Immunology 176 (4), 2373-2380, 2006
1982006
Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma
J Gunawardana, FC Chan, A Telenius, B Woolcock, R Kridel, KL Tan, ...
Nature genetics 46 (4), 329-335, 2014
1822014
Progression of disease within 24 months in follicular lymphoma is associated with reduced intratumoral immune infiltration
JWD Tobin, C Keane, J Gunawardana, P Mollee, S Birch, T Hoang, J Lee, ...
Journal of Clinical Oncology 37 (34), 3300, 2019
542019
Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor‐1 in childhood obesity: evidence of a procoagulant state
A Singh, GD Foster, J Gunawardana, TA McCoy, T Nguyen, ...
British journal of haematology 158 (4), 523-527, 2012
402012
Biology and therapy of primary mediastinal B‐cell lymphoma: current status and future directions
C Lees, C Keane, MK Gandhi, J Gunawardana
British journal of haematology 185 (1), 25-41, 2019
382019
Whole-blood tissue factor procoagulant activity is elevated in type 1 diabetes: effects of hyperglycemia and hyperinsulinemia
A Singh, G Boden, C Homko, J Gunawardana, AK Rao
Diabetes care 35 (6), 1322-1327, 2012
312012
Meningococcal porin PorB prevents cellular apoptosis in a Toll-like receptor 2-and NF-κB-independent manner
P Massari, J Gunawardana, X Liu, LM Wetzler
Infection and immunity 78 (3), 994-1003, 2010
292010
Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation
E Vigaṇ, J Gunawardana, A Mottok, T Van Tol, K Mak, FC Chan, ...
Blood, The Journal of the American Society of Hematology 131 (18), 2036-2046, 2018
242018
Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma
D Bararia, JA Hildebrand, S Stolz, S Haebe, S Alig, CP Trevisani, ...
Cell reports 31 (5), 107522, 2020
212020
The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma
C Keane, J Tobin, J Gunawardana, S Francis, G Gifford, S Gabrielli, A Gill, ...
European journal of haematology 103 (3), 200-207, 2019
212019
EBV microRNA-BHRF1-2-5p targets the 3′ UTR of immune checkpoint ligands PD-L1 and PD-L2
AS Cristino, J Nourse, RA West, MB Sabdia, SC Law, J Gunawardana, ...
Blood 134 (25), 2261-2270, 2019
202019
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
MK Gandhi, T Hoang, SC Law, S Brosda, K O’Rourke, JWD Tobin, F Vari, ...
Blood, The Journal of the American Society of Hematology 137 (11), 1468-1477, 2021
112021
Intra-Tumoral CD8+ T-Cells in Follicular Lymphoma Contain Large Clonal Expansions That Are Amenable to Dual-Checkpoint Blockade
K Nath, SC Law, MB Sabdia, LM De Long, M Shanavas, JWD Tobin, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
22019
Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma
K Nath, SC Law, MB Sabdia, J Gunawardana, LM de Long, D Sester, ...
Blood Advances 5 (12), 2644-2649, 2021
12021
Neoantigens Are Typically Associated with Intact HLA Class I Presentation in Early-Stage Follicular Lymphoma
H Tsang, AM Patch, C Keane, SC Law, J Gunawardana, P Blombery, ...
Blood 136, 37-38, 2020
12020
Genetic aberrations of NLRC5 are associated with downregulated MHC‐I antigen presentation and impaired T‐cell immunity in follicular lymphoma
J Gunawardana, JN Lee, K Bednarska, V Murigneux, LM de Long, ...
eJHaem 1 (2), 517-526, 2020
12020
EBV+ CNS LYMPHOMAS HAVE A DISTINCTIVE TUMOR MICROENVIRONMENT AND GENETIC PROFILE, WHICH IS AMENABLE TO COMBINATION 3RD PARTY EBV‐SPECIFIC CTL AND IBRUTINIB THERAPY
MK Gandhi, T Hoang, JW Tobin, SC Law, D Talaulikar, S Jain, F Vari, ...
Hematological Oncology 37, 130-132, 2019
12019
The tumor microenvironment is independently prognostic of conventional and clinicogenetic risk models in follicular lymphoma
JWD Tobin, C Keane, P Mollee, S Birch, C Gould, J Gunawardana, ...
Blood 130 (Supplement 1), 728-728, 2017
12017
The system can't perform the operation now. Try again later.
Articles 1–20